Angarus Therapeutics develops immuno-oncology therapies intended to respond to the urgent needs of cancer treatment.The therapy serves as checkpoint blockers on the innate immunity STING pathway, with preclinical data demonstrating that a combination of checkpoint blockers, both innate and adaptive, leads to long term survival, enabling patientswith a wide range of cancer treatments.Chih-Ping Liu established the company in Sunnyvale, California in 2018.

Biotechnology

Health Care

Therapeutics

Angarus Therapeutics

Angarus Therapeutics' headquarters in Sunnyvale, CA, United States

Description

People (1)

Randolph M. Johnson

Jobs